Picture of Directa Plus logo

DCTA Directa Plus News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsSpeculativeMicro CapSucker Stock

REG - Directa Plus PLC - Directorate Change




 



RNS Number : 3887M
Directa Plus PLC
21 January 2021
 

21 January 2021

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (596/2014) WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Resignation of Chief Financial Officer

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that Marco Ferrari, Chief Financial Officer, has tendered his resignation from the Company in order to pursue another business opportunity.

 

Marco will step down from the Board and leave the Company at the end of March 2021. In the interim, he will continue to run, with his team, the finance function of Directa Plus to ensure an orderly handover. In particular, Marco will oversee the preparation of the accounts for the year to 31 December 2020, which are expected to be substantially complete by the time of his departure and announced in April 2021.  The Company has already begun the search for a replacement and is confident of being able to recruit a high-quality replacement. Further announcements will be made in due course.

 

Giulio Cesareo, Founder and CEO of Directa Plus, said: "Although I am very sorry to see Marco leave, I recognise that other opportunities to add experience and new challenges can be hard to resist. On behalf of the Board, I would like to thank Marco for his hard work during his time with Directa Plus and wish him well for the future."

 

Marco Ferrari, CFO of Directa Plus, added: "I will miss the Directa Plus family.  I have learned a great deal at this company and my thanks are due to all of my colleagues for making such a rewarding working environment for this stage of my career."

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

For further information please visit www.directa-plus.com or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Pete Lynch

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products.  All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFELLVIIFIL

Recent news on Directa Plus

See all news